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Objective: To estimate the total incidence and direct medical expen-
diture in the treatment of osteoporotic fragility fracture in Korea.
Osteoporotic fragility fractures may cause a significant public health
problem which could dramatically change the quality of life for
patients and their families not only due to a loss of patient independ-
ence, significant disability and even death also enormous economic
burden. Korea is moving toward an aged society at the fastest pace
in the world. As with many other countries, Korea expects to see
rapid increase of osteoporotic fragility fracture. However, there are
no reports on the economic burden of osteoporotic fragility fracture
in Korea.
Methods: Total incidence and direct medical expenditures for the
treatment of osteoporotic fragility fracture were estimated using
Health Insurance Review and Assessment Service (HIRA) data
from 2011 to 2014.
Results: The incidence of fragility fracture is rapidly increasing with
increasing ageing population. Annual incidence of osteoporosis
related fragility fracture in Korea is about 1039454 cases in 2011,
1090256 cases in 2012, 11159446 cases in 2013 and 1149404 cases
in 2014 according to the HIRA data. Total annual medical expendi-
ture only for surgery was 170 million US dollar in 2010, 197 million
in 2013 increased almost 15% during the 3 years. Economic burden
due to osteoporotic fragility fracture will affect not only nation's
economy but also make economic crisis of individual family. That's
why secondary prevention of fragility fracture is important both soci-
ety and nation. Dedicated team approach could provide comprehen-
sive bone health care after fracture e including diagnosis,
treatment, education, and research for patients that have incurred a
fragility fracture. Systematic approach for prevention of the secon-
dary fracture including assessments, coordinates lab, radiology and
pharmacy services could offer specialized treatment. However, all
with the goal and focus of promoting bone health, reducing fracture
risks, accelerating healing, and preventing re-fractures is not yet
established in Korea.
Conclusions: Secondary fracture prevention system is strongly nec-
essary to improve the life quality for elderly person with osteoporosis
and to reduce the economic burden of society and nation.
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Objectives: Proportion of population aged 60 years or over is
expected to grow very rapidly in Korea and all over the world. Osteo-
porosis is one of the major geriatric diseases, however the study of
osteoporotic vertebral fracture has been underestimated in osteopor-
otic fracture treatment. we have investigated persistence ofosteoporosis medication and drug use factor in osteoporotic compres-
sion vertebral fracture patients.
Methods: Four hundred fifty-eight patients with osteoporotic verte-
bral fracture who underwent osteoporosis medication in our institu-
tion between January 2010 and February 2014, were retrospectively
analyzed. Male to female ratio was 403:55. Mean patients age was
75yrs (range: 50e95). The persistence of osteoporotic medication
were analyzed using Kaplan Meier survival analysis. Multiple fac-
tors analysis was performed using cox regression test. Gender,
age, types of drugs, duration, kinds of doctors, change of drug
were analyzed.
Results: Persistence of Osteoporotic medication were 52% at 6
month, 40% at 12 months, 28% at 24 months, 25% at 36 months.
Women were higher persistence than men (p < 0.05). There is no
difference between over 75yrs old patients and less (p > 0.05).
Kinds of drugs and dose interval significantly affect persistence
(p < 0.05). Persistence ratio was particularly higher in drug change
group (p < 0.0001). There is no difference between kinds of
doctors.
Conclusion: Overtime, persistence of osteoporotic medication in
osteoporotic vertebral fracture patients sharply decreased. Changing
drug group shows significantly higher sustained rate of the drug med-
ication. Patients also took SERM for a longer period than bisphosph-
onate. The authors considered that prescribing physician will be able
to increase the rate of osteoporosis drugs through the patient care and
education. The results of the study are useful in increasing persistence
of osteoporotic medicaiotion.0026
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Background: Muscle mass was known to related with bone mineral
density. However there were few data for affecting factor to this rela-
tionship. In this study, we investigated the affecting factor to the rela-
tionship between bone and muscle.
Subjects and Methods: The data from a population-based survey,
namely, The Korea National Health and Nutrition Examination Sur-
vey (KNHANES) IV (08-09) & V(10) (18,007 subjects), were ana-
lyzed. We studied the relating factor (anthropometric data and
insulin resistance) to bone mineral density (BMD)/[appendicular
lean mass(ALM)/(height)2].
Result: With increasing age, BMD/ALM(ht)2 was increasing in men
(B¼ 0.126, p< 0.001) but deceasing in women (B¼0.408,
p< 0.001). After adjusting age, fat mass (men: B¼0.186,
p< 0.001, women: B¼0.162, p< 0.001) and waist circumference
(men: B¼0.186, p< 0.001, women: B¼0.162, p< 0.001), fast-
ing insulin level (men: B¼0.108, p¼ 0.002, women: B¼0.088,
p¼ 0.016) was negatively related with BMD/ALM(ht)2. And insulin
resistance (HOMA-IR) was also negatively related with BMD/
ALM(ht)2 (men: B¼0.115, p< 0.001, women: B¼0.121,
p< 0.001). HDL cholesterol level had positive relation with BMD/
ALM(ht)2 (men: B¼ 0.081, p< 0.001, women: B¼ 0.115,
p< 0.001).
Conclusion: In this study, bone and muscle relation was differing
between men and women. And obesity and insulin resistance may
be weakening the relationship between bone and muscle.
